Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study

Kidney International
E K HoogeveenC D Stehouwer

Abstract

Microalbuminuria (MA) is a strong predictor of cardiovascular disease, but its causes are incompletely understood. Hyperhomocysteinemia is a recently recognized risk factor for cardiovascular disease independent of established risk factors. It is not known whether hyperhomocysteinemia is associated with MA, and thus could be a possible cause of microalbuminuria. We studied an age-, sex- and glucose-tolerance-stratified random sample of a 50- to 75-year old general Caucasian population (N = 680). The urinary albumin-to-creatinine ratio (ACR) was measured in an early morning spot urine sample. MA was defined as an ACR > 3.0 mg/mmol. The prevalence of MA was 4.3% (13 of 304) in subjects with normal glucose tolerance, 9.2% (17 of 185) in impaired glucose tolerance and 18.3% (30 of 164) in non-insulin-dependent diabetes mellitus (NIDDM); it was 3.7% (15 of 402) in subjects without hypertension and 17.9% (45 of 251) in those with hypertension. After adjusting for age, sex, glucose tolerance category, hypertension, dyslipidemia and smoking, the odds ratio [OR; 95% confidence interval (95%CI)] for MA per 5 mumol/liter total homocysteine increment was 1.33 (1.08 to 1.63). Additional adjustment for HbA1c, waist-hip ratio, protein intake ...Continue Reading

References

Apr 13, 1978·The New England Journal of Medicine·B M BrennerH D Humes
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Sep 1, 1992·Diabetes Care·T DeckertT Jensen
May 1, 1991·Scandinavian Journal of Clinical and Laboratory Investigation·B HultbergC D Agardh
Apr 1, 1989·Diabetologia·T DeckertA Kofoed-Enevoldsen
Oct 4, 1995·JAMA : the Journal of the American Medical Association·C J BousheyA G Motulsky
Dec 1, 1994·Scandinavian Journal of Clinical and Laboratory Investigation·C D AgardhB Hultberg
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·J C TsaiM E Lee
Dec 8, 1993·JAMA : the Journal of the American Medical Association·J SelhubI H Rosenberg
Feb 20, 1993·BMJ : British Medical Journal·J JohnstonD S O'Reilly
Jul 1, 1996·The Journal of Clinical Investigation·J Loscalzo
Feb 1, 1996·Scandinavian Journal of Clinical and Laboratory Investigation·M ArnadottirH Thysell
Jan 1, 1997·Kidney International·G RemuzziA Benigni
Jul 24, 1997·The New England Journal of Medicine·O NygårdS E Vollset
Aug 1, 1997·Kidney International·A B GuttormsenH Refsum
Dec 31, 1997·The New England Journal of Medicine·S Moll

❮ Previous
Next ❯

Citations

Apr 29, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Justine BacchettaPierre Cochat
Dec 4, 2001·Atherosclerosis·M C Audelin, J Genest
May 31, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Yuichiro MakitaAndrzej S Krolewski
May 4, 2011·The British Journal of Nutrition·Andrew P WakefieldHarold M Aukema
Jan 5, 2000·Journal of Internal Medicine·E K HoogeveenC D Stehouwer
Apr 25, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·A AmbroschH Lehnert
Jul 2, 1998·Kidney International·K Robinson, V W Dennis
Mar 22, 2001·Kidney International·L A HebertB H Rovin
Feb 19, 2005·Advances in Chronic Kidney Disease·Stephen P McDonald, Wendy E Hoy
Aug 29, 2003·The New England Journal of Medicine·Allon N Friedman
Mar 29, 2008·Metabolic Syndrome and Related Disorders·A BeckerC D A Stehouwer
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Harpal S Randeva
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·A MimranG Du Cailar
Oct 6, 2005·Current Opinion in Nephrology and Hypertension·Carmine Zoccali
Sep 18, 2002·Kidney International·Ronald M A HenryCoen D A Stehouwer
Oct 4, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Maya S P HuijbertsCoen D A Stehouwer
Dec 15, 2010·International Journal of Molecular Sciences·Chunmei Gu, Huiyong Xu
Sep 27, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Katherine R TuttleMark E Molitch
Jun 12, 2003·Clinical and Experimental Hypertension : CHE·Francisco Rodríguez-EsparragónCarlos M Ferrario
Dec 8, 2004·Blood Pressure·Paolo Verdecchia, Gian Paolo Reboldi
Oct 22, 2005·Journal of Internal Medicine·S S Soedamah-MuthuUNKNOWN Eurodiab ProspectivE Complications Study Group
Feb 27, 2003·Journal of Internal Medicine·A BeckerC D A Stehouwer
Aug 17, 2004·American Heart Journal·Peter A McCulloughRobert M Califf
Sep 25, 2014·Diabetes Care·Katherine R TuttleMark E Molitch
Oct 29, 2002·Diabetes Care·Allon N FriedmanUNKNOWN Collaborative Study Group
Feb 22, 2014·Diabetes Care·George L Bakris, Mark Molitch
Feb 20, 2002·European Journal of Clinical Investigation·A BeckerC D A Stehouwer
Sep 16, 2009·Seminars in Nephrology·Katherine R TuttleHolly Kramer
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Elizabeth M WroneUNKNOWN Third National Health and Nutrition Examination Survey
Sep 14, 1999·Metabolism: Clinical and Experimental·S P StablerR W Schrier
Feb 19, 2002·Journal of Human Hypertension·R PedrinelliM Mariani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.